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ABSTRACT 
The cleft lip and/or palate are among the most common congenital anomalies 
that occur in early development. Cytokines play an important role in the 
proliferation, growth, differentiation, survival and the functional activity of 
many cells and the upregulation of cytokines might be involved in the patho-
logical processes of the maxillofacial region. The purpose of our study was to 
evaluate the expression of pro-inflammatory and anti-inflammatory cytokines 
in the facial tissue of children with the cleft lip and palate.  
The study involved 14 patients with the unilateral cleft lip and palate at the 
age of three months to 10 years and five months. Soft and hard palate tissue 
samples were collected during the primary cleft operation if the parents had 
given their informed written consent. All the tissue samples were stained with 
hematoxylin and eosin and by immunohistochemistry for IL-1α, IL-6, IL-8, IL-
10 and TNF-α. The intensity of immunostaining was graded semiquanti-
tatively. 
IL-1α containing structures were not detected in any of soft, cartilage and 
bone tissue samples, meanwhile IL-6, IL-8, IL-10 and TNF-α showed explicit 
expression. The expression of IL 6 was observed in the tissues of all the patients. 
IL-6 positive cells were found in the range from no positive to moderate of 
positive structures in the visual field. IL-8 positive osteocytes were found in the 
range from few positive to moderate, but IL-8 positive chondrocytes were 
found in abundance. IL-10 was richly secreted by osteocytes in bone and by 
chondrocytes in cartilage obtained from all the cases of plastic surgery. In all the 
cases we also observed numerous IL-10 positive gingival epithelial cells.   Cytokines expression in orofacial clefts  |  265 
Despite these data obtained, moderate to numerous macrophages and neutro-
phils expressed TNF-α. 
The sporadical and scarce expression of IL-6 indicates its insignificant role 
in the cleft lip and palate affected tissue. Rich cytokine IL-10 expression proves 
the compensated local anti-inflammatory effects of the cleft affected soft and 
hard tissue. 
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INTRODUCTION 
The morphogenetic cleft lip and/or palate (CL/P) affected tissue study has 
become very significant nowadays. CL/P is among the most common con-
genital anomaly that arise in the early development and affecting approximately 
2 per 1,000 newborns worldwide [1, 2]. Abnormal facial tissue development 
during gestation is caused by multiple genetic and environmental factors and 
this may result in local changes in growth factors, the extracellular matrix, cell 
adhesion molecules and cytokines [1, 3]. 
Cytokines are pleiotropic peptides, which are involved in numerous bio-
logical processes such as in the proliferation, growth, differentiation, survival 
and functional activity of many cells [4]. There are data about the cytokines 
role in the embryo growth and differentiation, as well as inflammation and the 
tissue remodeling [5, 6]. Traditionally, these small, nonstructural proteins are 
subdivided into following families: interleukins, growth factors, chemokines, 
colony-stimulating factors, interferons, the transforming growth factor and the 
tumor necrosis factor families [7]. It should be noted that interleukins and 
growth factors are present in skull tissues at the time of active differentiation 
and morphogenesis [8]. Further cytokines are polymorphic, which means that 
the expression can vary widely between individuals, and this may be genetically 
controlled [9]. A number of studies showed that the damages in different 
sections of immunity are significant causes of the pathological processes of 
m a x i l l o f a c i a l  r e g i o n  [ 1 0 ,  1 1 ] .  T h e  a n a l y s e s  o f  c y t o k i n e s  d i s t r i b u t i o n  i n  t h e  
orofacial region constitute the key to understanding the etiopathology of 
various diseases. Therefore, using an immunohistochemical method many 
studies reported the expression of interleukin – 1 (IL-1), interleukin – 6 (IL-6), 
interleukin – 8 (IL-8) and tumor necrosis factor alpha (TNF-α) in the 
squamous cell carcinoma of the palate tissue and diseased periodontal tissues 
[4, 12, 13]. Inoyatov et al. (2012) reported that the cytokine level for IL-1, 266  |  L. Smane, M. Pilmane, I. Akota 
TNF, interferon-gamma in the blood serum increasing under the congenital 
cleft [10]. Moreover, still a little is known about the local expression of 
inflammatory cytokines in the facial tissue of children with the cleft lip and 
palate. 
The aim of this study was to evaluate the expression of pro-inflammatory 
cytokines such as interleukin 1 alpha (IL-1α), IL-6, IL-8, TNF-α and anti-
inflammatory cytokine interleukin-10 (IL-10) in the facial tissue of the children 
with the unilateral cleft lip and palate. 
 
 
MATERIAL AND METHODS 
Patients 
The study involved 14 children with the unilateral cleft lip and palate at the age 
of three months to 10 years and five months. The samples of soft and hard 
palate tissue were collected during the surgical procedure from the borders of 
the cleft region. All the information about the patients is summarized in Table 
1. This study has been independently reviewed and approved by the local 
Ethical Committee of Riga Stradins University (2007), and written informed 
consent was obtained from all the parents after the nature of the study had 
been fully explained. 
 
Table 1. Information about the patients 
Patient  Gender  Age  Plastic surgery 
procedure  Material 
No. 1  F  9 years 4 
months 
Rhinoplasty  Bone tissue from spina nasalis 
anterior maxillae 
No. 2  F  9 years 4 
months 
Rhinoplasty Cartilage  from  septum nasale 
No. 3  M  7 years 7 
months 
Rhinoplasty  Bone tissue from spina nasalis 
anterior maxillae 
No. 4  M  7 years 7 
months 
Rhinoplasty Cartilage  from  septum nasale 
No. 5  M  10 years 5 
months 
Osteoplasty  Bone tissue from processus alveolaris 
No. 6  F  7 years 3 
months 
Osteoplasty  Bone tissue from processus alveolaris 
No. 7  F  8 years  Rhinoplasty  Cartilage from septum nasale 
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Table 1. Continuation 
Patient  Gender  Age  Plastic surgery 
procedure  Material 
No. 8  F  8 years  Rhinoplasty  Bone tissue from spina nasalis 
anterior maxillae 
No. 9  M  8 years 5 
months 
Osteoplasty  Bone tissue from processus alveolaris 
No. 10  F  7 years 10 
months 
Osteoplasty   Bone tissue from processus 
alveolaris 
No. 11  M  4 months   Lip plastic  Cleft lip region 
No. 12  M  4 months  Lip plastic  Cleft lip region 
No. 13  M  3 months  Lip plastic  Cleft lip region 
No. 14  M  4 months  Lip plastic  Cleft lip region 
 
 
Methods 
For conventional light microscopy and immunohistochemistry tissues were 
fixed for a day in the mixture of 2% formaldehyde and 0.2% picric acid in 0.1 M 
phosphate buffer (pH 7.2). Following this, they were rinsed in the thyroid 
buffer, containing 10% sacharose for 12 hours, and then samples were 
embedded into paraffin. Five micrometer thick sections were cut from each 
block, mounted on glass slides, then de-paraffinized, rehydrated through 
graded alcohol solutions and colored with hematoxylin-eosin.  
Five-micrometer thick sections were cut from the same blocks and placed 
on polylisine coated slides for the immunohistochemical analysis. Sections 
were proceeded for the detection of the following interleukins: interleukin-1 
alpha (IL-1α (B-7): sc-9983, obtained from the mouse, working dilution 1:50, 
Santa Cruz Biotechnology, Inc., USA), interleukin-6 (IL-6 (NYRhIL6): sc-
73319, obtained from the mouse, working dilution 1:50, Santa Cruz 
Biotechnology, Inc., USA), interleukin-8 (IL-8 (C-19): sc-1269, obtained from 
the goat, working dilution 1:50, Santa Cruz Biotechnology, Inc., USA), 
interleukin-10 (IL-10, code ab 34843, obtained from the rabbit, working 
dilution 1:400, Abcam, Cambridge, UK), tumor necrosis factor alpha (TNF-α, 
code ab 6671, obtained from the rabbit, working dilution 1:100, Abcam, 
Cambridge, UK) by use of Hsu et al. (1981) biotin – streptavidin immuno-
histochemical method. 
Our findings were illustrated using Leica DC 300F camera and the image 
processing and analysis software Image-Pro Plus Version 6.0. 268  |  L. Smane, M. Pilmane, I. Akota 
The intensity of immunostaining was graded semi-quantitatively. The scale 
was the following: “0” – no positive structures found in the the visual field, 
“0/+” – occasional positive structures seen in the visual field, “+” – few immu-
noreactive structures seen in the visual field, “++” – moderate number of 
immunoreactive structures seen in the visual field, “+++” – numerous immu-
noreactive structures seen in the visual field, and “++++” – the abundance of 
immunoreactive structures seen in the visual field (Pilmane et al. 1998). 
 
 
RESULTS 
Routine haematoxylin and eosin slides showed patchy infiltrates with inflam-
matory cells vacuolization in the polymorphic epithelial cell layer. 
IL-1α-containing structures were not detected in any of the soft, cartilage 
and bone tissue samples, meanwhile IL-6, IL-8, IL-10 and TNF-α showed 
explicit expression. 
The expression of IL-6 was also observed in the tissues of all the patients. 
IL-6 positive cells were found in the range from the absence to moderate (++) 
of positive structures in the visual field. We observed few (+) to moderate (++) 
positive osteocytes (Figure 1), few (+) to moderate (++) immunoreactive 
hyaline cartilage cells and many positive cells in the cartilage growth zone 
(Figure 2) and few positive epithelial cells (Figure 3) into the gingival 
epithelium. 
IL-8 also was seen in the tissue samples of all the patients. IL-8 positive 
osteocytes were found in the range from few (+) positive to moderate (++) of 
positive structures in the visual field (Figure 4). It should be noted that IL-8 
presented the abundance of richly stained hyaline cartilage chondrocytes 
(Figure 5).  
Interestingly, IL-10 was richly secreted by osteocytes in bone obtained from 
all the cases of plastic surgery, as well as by chodrocytes in the hyaline cartilage 
obtained from all the cases of plastic surgery. IL-10 positive structures mostly 
varied from numerous (+++) positive structures to abundance (++++) of 
positive structures in the visual field. Therein we detected many immuno-
reactive hyaline cartilage cells and many positive cells in the cartilage growth 
zone as well as many osteocytes (Figure 6). In all the cases we also observed 
numerous (+++) IL-10 positive gingival epithelial cells.  
Finally, despite these data moderate (++) to numerous (+++) macrophages 
and neutrophils expressed TNF-α (Figure 7). 
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Figure 1. Few IL-6 positive osteocytes in 
the bone from spina nasalis anterior 
maxillae of 9 years and 4 months old child. 
IL-6 IMH, X 400. 
 
Figure 2. Moderate number of IL-6 
positive chondrocytes in the mature and 
proliferation zone. IL-6 IMH, X 250. 
 
 
Figure 3. Few IL-1α positive epithelial 
cells into the gingival epithelium of 4 
months old child. IL-1α IMH, X 250. 
 
Figure 4. Moderate number of IL-8 
positive osteocytes in the bone from spina 
nasalis anterior maxillae of 9 years and 4 
months old child. IL-8 IMH, X 250. 
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Figure 5. Abundance of IL-8 positive 
chondrocytes in the hyaline cartilage from 
septum nasale of 7 years and 7 months 
old child. IL-8 IMH, X 250. 
 
Figure 6. Abundance of IL-10 positive 
chondrocytes in the hyaline cartilage from 
septum nasale of 7 years and 7 months 
old child. IL-10 IMH, X 250. 
 
 
Figure 7. Moderate number of TNF-α containing macrophages and neutrophils in the soft 
tissue from lip region of 4 months old child. TNF-α IMH, X 200. 
 
 
DISCUSSION 
Cytokines are of central importance for the regulation of inflammation, tissue 
remodeling, and embryogenic development [5, 6]. Yet little is known about the 
local expression of pro- inflammatory cytokines in the cleft lip and palate 
tissues.  
The expression of interleukin-6 (IL-6) was observed in the tissues of all the 
patients. Therein IL-6 showed slight elevated expression in gingival epithelial,   Cytokines expression in orofacial clefts  |  271 
hyaline cartilage and hyaline cartilage growth zone cells as well as osteocytes. 
IL-6 is a well known major inflammatory and fibrogenic cytokine and it has a 
wide range of biological activities including the regulation biological functions 
of connective tissue cells (e.g. fibroblasts), the expression of proteases, 
inhibiting the formation of the extracellular matrix, the immune regulation and 
the stimulation of acute-phase reactants [14, 15, 16]. IL-6 is involved in the 
regulation of bone and cartilage cells functions, but its role in supportive tissue 
metabolism is uncertain [17]. Bodo et al. (1998) reported that changes 
between TGF-β3 and IL-6 signal transduction pathways are involved in the 
induction of the cleft palate [18]. The role of tumor growth factor beta3 
(TGFβ3) expression in orofacial clefts has been investigated for several years. 
TGF-β3 significantly down-regulates IL-6 secretion in the cleft lip and palate 
fibroblasts [19]. Further IL-6 reduces connective macromolecule production 
u n l i k e  T G F - β  [ 2 0 ,  2 1 ] .  I L - 6  e x p r e s s i o n  i n  t h e  m a t e r i a l  f r o m  c l e f t s  a r e a s  
possibly might be explained with the necessity for an inhibitory effect on 
extracellular matrix components levels. In our material the sporadical and 
scarce expression of IL-6 indicates its insignificant role in the cleft lip and 
palate affected tissue. A number of studies reported that the TGF-β is involved 
in regulating not only the IL-6 network, but also interleukin-1 alpha (IL-1α) 
[22].  
It should be noted that IL-1α containing structures were not detected in any 
of soft, cartilage and bone tissue samples from the patients with the clefts lip 
and palate. IL-1α is a major pro-inflammatory cytokine. In addition, this 
cytokine has been supported to be a potent regulator of fibroblast proliferation, 
and is also known to induce the synthesis of the basic fibroblast growth factor 
(bFGF) in human osteoblasts and gingival fibroblasts [23, 24]. In its turn, 
bFGF is involved in various cellular processes such as in cell proliferation 
associated with wound healing, differentiation and cell migration [25]. In this 
study TNF-α was observed in macrophages and neutrophils. Like IL-1, TNF-α 
induces inflammatory response and is a central regulator of the innate immune 
response as well as induces the expression of proteases and inhibits the 
formation of the extracellular matrix and promotes cells to secrete pro-
inflammatory cytokines [15, 26, 27, 28], and these functions may play a role in 
our patients also.  
Interleukin-8 (IL-8) was observed in the cells of hyaline cartilage, bone and 
soft tissue. Some variations in the distribution of cytokines may be explained by 
polymorphism of interleukins genes [9]. This pro-inflammatory cytokine is a 
neutrophil chemoatractant and activator, play a critical role in inflammation 272  |  L. Smane, M. Pilmane, I. Akota 
and host defense and is synthesized by fibroblasts from different tissues, 
chondrocytes and several types of epithelial cells [29, 30]. A moderate number 
of IL-8 positive cells in our patients my play a role in these functions. IL-8 
immunoreactivity is associated with many orofacial region diseases such as the 
periodontal disease [31]. In support of this, Huang et al. (2001) showed that 
the expression of IL-8 by gingival epithelial cells increases the following 
interaction with several periodontal microbes [31].  
Interestingly, interleukin-10 (IL-10) presented the abundance of richly 
stained chondrocytes, osteocytes, fibroblasts, neutrophils, and macrophages, 
the cells of gingival epithelium, sebaceous glands and hair follicles in all the 
patients. This cytokine is a true anti-inflammatory cytokine [32]. Its presence 
suggests the presence of inflammation in the bone, cartilage and soft tissue, 
even though IL-1α absence may suggests the absence of inflammation in the 
same tissues. 
We concluded that the sporadical and scarce expression of IL-6 indicates its 
insignificant role in the cleft lip and palate affected tissue. Rich cytokine IL-10 
expression proves the compensated local anti-inflammatory effects of the cleft 
affected soft and hard tissue. 
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